Reuters logo
BRIEF-Capricor says results from Duchenne muscular dystrophy trial to be presented at AHA late-breaking session
October 25, 2017 / 11:08 AM / 24 days ago

BRIEF-Capricor says results from Duchenne muscular dystrophy trial to be presented at AHA late-breaking session

Oct 25 (Reuters) - Capricor Therapeutics Inc-

* Capricor announces 12-month results from HOPE-1 trial in Duchenne muscular dystrophy to be presented at AHA late-breaking session Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below